runinggirl2016, here is the Otezla data from the ESTEEM 1 and ESTEEM 2 trials,http://www.otezla.net/plaque-psoriasis/clinical-efficacy/study-design/. Please note below the poster presentations "Patients greater than or equal to 18 years of age (N=1257) with moderate to severe plaque psoriasis were randomized to placebo (n=419) or Otezla (n=836) given orally BID. These studies had a similar design through week 32".
runinggirl2016, here is the Otezla data from the ESTEEM 1 and ESTEEM 2 trials,http://www.otezla.net/plaque-psoriasis/clinical-efficacy/study-design/. Please note below the poster presentations "Patients greater than or equal to 18 years of age (N=1257) with moderate to severe plaque psoriasis were randomized to placebo (n=419) or Otezla (n=836) given orally BID. These studies had a similar design through week 32".
News 
Market Data 
Discover 
